BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 195.8 SEK 29.33% Market Closed
Market Cap: 17.3B SEK
Have any thoughts about
BioArctic AB?
Write Note

BioArctic AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioArctic AB
Cost of Revenue Peer Comparison

Comparables:
BIOG B
BONEX
B
BINV
VITR
SOBI

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BioArctic AB
STO:BIOA B
Cost of Revenue
-kr50.9m
CAGR 3-Years
-30%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Cost of Revenue
-kr346.3m
CAGR 3-Years
-20%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Cost of Revenue
-kr61.6m
CAGR 3-Years
-41%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
B
BioInvent International AB
STO:BINV
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Cost of Revenue
-kr1.5B
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-25%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Cost of Revenue
-kr5.4B
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-18%

See Also

What is BioArctic AB's Cost of Revenue?
Cost of Revenue
-50.9m SEK

Based on the financial report for Dec 31, 2023, BioArctic AB's Cost of Revenue amounts to -50.9m SEK.

What is BioArctic AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-10%

Over the last year, the Cost of Revenue growth was -54%. The average annual Cost of Revenue growth rates for BioArctic AB have been -30% over the past three years , -10% over the past five years .

Back to Top